Breaking Down Amylyx Pharma: 9 Analysts Share Their Views
Breaking Down Amylyx Pharma: 9 Analysts Share Their Views
细分 Amylyx Pharma：9 位分析师分享他们的观点
Amylyx Pharma (NASDAQ:AMLX) underwent analysis by 9 analysts in the last quarter, revealing a spectrum of viewpoints from bullish to bearish.
Amylyx Pharma（纳斯达克股票代码：AMLX）在上个季度接受了9位分析师的分析，揭示了从看涨到看跌的一系列观点。
The following table summarizes their recent ratings, shedding light on the changing sentiments within the past 30 days and comparing them to the preceding months.
下表汇总了他们最近的评级，阐明了过去30天内情绪的变化，并将其与前几个月进行了比较。
Insights from analysts' 12-month price targets are revealed, presenting an average target of $9.22, a high estimate of $32.00, and a low estimate of $3.00. Highlighting a 66.73% decrease, the current average has fallen from the previous average price target of $27.71.
分析师12个月目标股价的见解已经公布，平均目标股价为9.22美元，最高估计为32.00美元，低估值为3.00美元。当前的平均价格已从之前的27.71美元的平均目标股价有所下降，这凸显了66.73％的跌幅。
Interpreting Analyst Ratings: A Closer Look
解读分析师评级：仔细观察
A comprehensive examination of how financial experts perceive Amylyx Pharma is derived...
对金融专家如何看待Amy...
登录免费看全文
登录/注册